Skip to main content

ArriVent BioPharma, Inc.

AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001868279

No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

13F holders, Q1 2026

Institutional positions in ArriVent BioPharma, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
139
+18 vs. Q4 2025
Shares held
42.1M
+3.85M (+10.1%) vs. Q4 2025
Total value
$969.5M
+$196.8M (+25.5%) vs. Q4 2025
New holders
35
58 more added
Sold out
17
28 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AVBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 139 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 53 institutionsQ2 2024: 54 institutionsQ3 2024: 68 institutionsQ4 2024: 80 institutionsQ1 2025: 83 institutionsQ2 2025: 99 institutionsQ3 2025: 106 institutionsQ4 2025: 122 institutionsQ1 2026: 139 institutionsQ2 2026: 157 institutions
Value heldQ1 2026: $969.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $388.9MQ2 2024: $404.2MQ3 2024: $612.3MQ4 2024: $757.5MQ1 2025: $539.3MQ2 2025: $732.0MQ3 2025: $712.4MQ4 2025: $810.3MQ1 2026: $969.5MQ2 2026: $1.60B
Institutions holding AVBP and their total value by quarter
QuarterHoldersValue
Q2 2026157$1.60B
Q1 2026139$969.5M
Q4 2025122$810.3M
Q3 2025106$712.4M
Q2 202599$732.0M
Q1 202583$539.3M
Q4 202480$757.5M
Q3 202468$612.3M
Q2 202454$404.2M
Q1 202453$388.9M
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding ArriVent BioPharma, Inc.; share changes are against Q4 2025.

Institutions holding AVBP in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Bank of America Corp80,208$1.85M0.00%+23,687+41.9%Added
E Fund Management Co., Ltd.93,953$2.17M0.06%+93,953New
Burkehill Global Management, LP100,000$2.31M0.11%00.0%Unchanged
Polymer Capital Management (HK) LTD122,276$2.82M0.40%+122,276New
Dimensional Fund Advisors LP126,525$2.92M0.00%+111,782+758.2%Added
Morgan Stanley128,546$2.97M0.00%+30,956+31.7%Added
ADAR1 Capital Management, LLC141,814$3.27M0.20%+141,814New
Woodline Partners LP147,639$3.41M0.01%+253+0.2%Added
Citadel Advisors LLC166,157$3.83M0.00%−292,345−63.8%Reduced
Affinity Asset Advisors, LLC175,000$4.04M0.24%+25,000+16.7%Added
Ameriprise Financial Inc180,028$4.15M0.00%+61,543+51.9%Added
Vanguard Fiduciary Trust Co217,127$5.01M0.00%+217,127New
Nomura Holdings Inc242,050$5.58M0.05%+242,050New
Vanguard Portfolio Management LLC253,852$5.86M0.00%+253,852New
Charles Schwab Investment Management Inc258,772$5.97M0.00%+8,184+3.3%Added
Northern Trust Corp268,812$6.20M0.00%+23,213+9.5%Added
Logos Global Management LP350,000$8.07M0.42%+350,000New
D. E. Shaw & Co., Inc.368,795$8.51M0.01%+135,471+58.1%Added
Millennium Management LLC425,923$9.83M0.01%+143,971+51.1%Added
Balyasny Asset Management LLC426,281$9.83M0.02%+383,251+890.7%Added
UBS Group AG486,263$11.2M0.00%+35,343+7.8%Added
Fund 1 Investments, LLC499,990$11.5M1.50%−65,861−11.6%Reduced
SC China Holding Ltd663,308$14.0M0.92%00.0%Unchanged
Point72 Asset Management, L.P.748,195$17.3M0.03%+531,535+245.3%Added
Geode Capital Management, LLC803,652$18.5M0.00%+50,133+6.7%Added
Goldman Sachs Group Inc853,427$19.7M0.00%+110,901+14.9%Added
Vivo Capital, LLC885,916$20.4M1.70%+885,916New
State Street Corp1,421,415$32.8M0.00%+329,435+30.2%Added
General Catalyst Group Management, LLC1,494,786$34.5M18.79%00.0%Unchanged
Vanguard Capital Management LLC1,528,893$35.3M0.00%+1,528,893New
Sofinnova Investments, Inc.1,696,752$39.1M1.96%00.0%Unchanged
Novo Holdings A/S1,942,142$44.8M3.63%00.0%Unchanged
Octagon Capital Advisors LP1,971,054$45.5M5.03%00.0%Unchanged
BlackRock, Inc.2,530,301$58.4M0.00%+157,463+6.6%Added
FMR LLC3,016,132$69.6M0.00%−687,440−18.6%Reduced
OrbiMed Advisors LLC3,027,328$69.8M1.59%00.0%Unchanged
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)3,929,117$90.6M5.42%00.0%Unchanged
Infinitum Asset Management, LLC4,148,923$95.7M11.98%+25,000+0.6%Added
Suvretta Capital Management, LLC4,401,083$101.5M2.75%+295,048+7.2%Added
AIHC Capital Management Ltd0$00.00%−644,788−100.0%Sold out
Rosalind Advisors, Inc.0$00.00%−215,871−100.0%Sold out
Hidden Lake Asset Management LP0$00.00%−152,448−100.0%Sold out
Simplex Trading, LLC0$00.00%−45,558−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−37,100−100.0%Sold out
Anson Funds Management LP0$00.00%−35,366−100.0%Sold out
NEOS Investment Management LLC0$00.00%−32,487−100.0%Sold out
Tema ETFs LLC0$00.00%−32,007−100.0%Sold out
Walleye Capital LLC0$00.00%−22,115−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−16,635−100.0%Sold out
Virtu Financial LLC0$00.00%−11,300−100.0%Sold out
Group One Trading, L.P.0$00.00%−2,854−100.0%Sold out
Quest Partners LLC0$00.00%−2,800−100.0%Sold out
Amalgamated Bank0$00.00%−927−100.0%Sold out
DV Trading LLC0$00.00%−683−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−111−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−73−100.0%Sold out
Vanguard Group Inc––––Not filed